Perspective Therapeutics Stock Discussion

Neutral after earnings report. Here are the levels to watch this week.
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$  

$Perspective Therapeutics (CATX.US)$ lots of positive of things happening here.  just curious how new of r/s is going to affect that?

$Salarius Pharmaceuticals (SLRX.US)$ 1:8
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20

$Perspective Therapeutics (CATX.US)$ 1346. inflow

$Perspective Therapeutics (CATX.US)$ if 3 cents to the better and inflow of cash great whose killing the stock should be bullish  he needs booting

$Perspective Therapeutics (CATX.US)$ Perspective Therapeutics Q1 2024 GAAP EPS $(0.02) Beats $(0.03) Estimate, Sales $325.000K Up From $233.000K YoY

$Perspective Therapeutics (CATX.US)$ minor pull back done well in 2 weeks🍖🍖

$Perspective Therapeutics (CATX.US)$ Benzinga· 4 mins ago
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors

US Cancer Drug Company $Perspective Therapeutics (CATX.US)$ received widespread market attention at two separate industry conferences this week as pharmaceutical giants spend billions of dollars to acquire startups that develop new methods of treating cancer using radiation.
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also...